Author

L. Mariani

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Assay:CUT&Tag· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Beshirova· 1 shared A. Buck· 1 shared A. Gerber· 1 shared A. Heider· 1 shared A. P. Shaw· 1 shared A. Shilatifard· 1 shared B. F. Pugh· 1 shared B. J. Venters· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Beshirova

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker

T. A. Martins, N. Tatari, D. Kaymak, S. Hogan, E. M. Bartoszek, R. Wieboldt, M.-F. Ritz, A. Buck, M. McDaid, A. Gerber, A. Beshirova, M. M. Etter, A. Heider, T. Shekarian, H. Mohamed, , G. Hutter

This paper develops a CAR T cell therapy that secretes a CD47 blocker to enhance anti-EGFRvIII efficacy against glioblastoma by modulating the tumor microenvironment.

bioRxiv · Aug 31, 2023Cancer Biology

A ChIP-exo screen of 887 PCRP transcription factor antibodies in human cells

W. K. Lai, L. Mariani, G. Rothschild, E. R. Smith, B. J. Venters, T. R. Blanda, P. K. Kuntala, K. Bocklund, J. Mairose, S. N. Dweikat, K. Mistretta, M. J. Rossi, D. James, J. T. Anderson, S. K. Phanor, , B. F. Pugh

The paper evaluates 887 PCRP antibodies against human transcription factors using ChIP-exo and other assays, identifying 5% as strong candidates and 34% as warranting further testing.

bioRxiv · Jun 8, 2020Biochemistry